BioLineRx Risk Adjusted Performance
| BLRX Stock | | | USD 3.41 0.06 1.79% |
Risk-Adjusted Performance (RAP) measures the return an equity would have generated if it carried the same total risk (standard deviation) as the market. Derived from the Sharpe Ratio, RAP is expressed in percentage terms, making direct comparison across assets with different volatility profiles straightforward. Below is BioLineRx's current Risk Adjusted Performance with peer comparisons and related risk metrics.
Current Risk Adjusted Performance Value
BioLineRx carries a Risk Adjusted Performance of 0.0746, consistent with positive but modest risk-adjusted return. BioLineRx has produced a positive return relative to risk, though the margin is limited.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | 0.0746 | |
Risk Adjusted Performance Peers Comparison
The peer group averages -0.04 for Risk Adjusted Performance, with BioLineRx at 0.0746 falling above that level. Readings span -0.5078 (Aditxt Inc) to 0.1884 (SeaStar Medical Holding). BioLineRx's risk-adjusted return exceeds the peer average, indicating more efficient compensation for risk taken.
Risk Adjusted Performance Relative To Other Indicators
The chart below plots Risk Adjusted Performance against Maximum Drawdown for BioLineRx and its peers. Each point represents one equity — position along the horizontal axis shows Risk Adjusted Performance while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
BioLineRx's Maximum Drawdown of
28.36 runs about
380.17 times its Risk Adjusted Performance of
0.07 . This indicates Maximum Drawdown substantially exceeds Risk Adjusted Performance for BioLineRx.
Methodology, Assumptions & Data Sources
The current Risk Adjusted Performance for BioLineRx is 0.0746. BioLineRx's Risk Adjusted Performance is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. The underlying data comes from exchange-reported daily closes with corporate action adjustments applied where relevant. The calculation assumes continuous price data across the selected period. All readings are presented as reference data.
Other Technical Indicators